Clinical features and outcomes of patients in different age groups with non-valvular atrial fibrillation receiving oral anticoagulants

BACKGROUND: Patients with non-valvular atrial fibrillation (NVAF) need prophylactically antithrombotic therapies to reduce the risk of stroke. We hypothesized that the prognostic benefits of prophylactic antithrombotic therapies outweighed the bleeding risk among very elderly (≥85 years old) patient...

Descripción completa

Detalles Bibliográficos
Autores principales: O, U Fan, Chong, Tou Kun, Wei, Yulin, Paudel, Bishow, Giudici, Michael C., Wong, Chi Wa, Lei, Wai Kit, Chen, Jian, Wu, Wei, Liu, Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968574/
https://www.ncbi.nlm.nih.gov/pubmed/35372665
http://dx.doi.org/10.1016/j.ijcha.2022.101009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968574/
https://www.ncbi.nlm.nih.gov/pubmed/35372665
http://dx.doi.org/10.1016/j.ijcha.2022.101009

Ejemplares similares